ArticleCardiovascular diabetology2014

Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.

Sachiko Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.